Related Experiment Video
Updated: Jul 5, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis
Hongjie Yao1, Pingxin Li, Bryan J Venters
1Center for Gene Regulation, Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA 16802, USA.
Abstract:
Protein Arg methyltransferases function as coactivators of the tumor suppressor p53 to regulate gene expression. Peptidylarginine deiminase 4 (PAD4/PADI4) counteracts the functions of protein Arg methyltransferases in gene regulation by deimination and demethylimination. Here we show that the expression of a tumor suppressor gene, OKL38, is activated by the inhibition of PAD4 or the activation of p53 following DNA damage. Chromatin immunoprecipitation assays showed a dynamic change of p53 and PAD4 occupancy and histone Arg modifications at the OKL38 promoter during DNA damage, suggesting a direct role of PAD4 and p53 in the expression of OKL38. Furthermore, we found that OKL38 induces apoptosis through localization to mitochondria and induction of cytochrome c release. Together, our studies identify OKL38 as a novel p53 target gene that is regulated by PAD4 and plays a role in apoptosis.
Insights
The tumor suppressor gene OKL38 is activated by inhibiting PAD4 or activating p53 after DNA damage. OKL38 triggers apoptosis by releasing cytochrome c from mitochondria.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Protein Arg methyltransferases are coactivators of tumor suppressor p53, regulating gene expression.
- Peptidylarginine deiminase 4 (PAD4) antagonizes methyltransferases through deimination and demethylimination.
- Understanding the interplay between p53, PAD4, and gene regulation is crucial for cancer research.
Purpose of the Study:
- To investigate the regulation of the tumor suppressor gene OKL38.
- To elucidate the roles of p53 and PAD4 in OKL38 gene expression.
- To determine the function of OKL38 in cellular processes, particularly apoptosis.
Main Methods:
- Chromatin immunoprecipitation (ChIP) assays to assess protein occupancy and histone modifications.
- DNA damage induction to study gene expression changes.
- Mitochondrial localization studies and cytochrome c release assays.
Main Results:
- OKL38 expression is activated by PAD4 inhibition or p53 activation following DNA damage.
- p53 and PAD4 dynamically interact at the OKL38 promoter during DNA damage.
- OKL38 localizes to mitochondria and induces cytochrome c release, triggering apoptosis.
Conclusions:
- OKL38 is identified as a novel p53 target gene.
- PAD4 regulates OKL38 expression, influencing its role in apoptosis.
- OKL38 plays a significant role in initiating apoptosis via mitochondrial pathways.
More Related Videos
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
09:32Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle